找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Essential Pharmaceutics; Ashlee D. Brunaugh,Hugh D. C. Smyth,Robert O. Will Textbook 2019 American Association of Pharmaceutical Scientist

[復(fù)制鏈接]
樓主: 方面
31#
發(fā)表于 2025-3-27 00:03:26 | 只看該作者
https://doi.org/10.1007/0-387-28273-4e discussed, including particle settling, flocculation, particle aggregation, viscosity, zeta potential, and Ostwald ripening are discussed. Methods of particle size reduction are introduced, including those to produce nanoparticles. An extensive discussion of relevant excipients is also included.
32#
發(fā)表于 2025-3-27 02:06:58 | 只看該作者
Why Technical Solutions are Insufficientanisms for drug transport through the skin, in vitro analytical techniques, and methods to increase drug permeation. Commonly used formulation approaches such as semisolid dosage forms and transdermal patches are also discussed.
33#
發(fā)表于 2025-3-27 08:15:41 | 只看該作者
https://doi.org/10.1007/978-94-011-4321-9, as are the mechanisms for overcoming these barriers through delivery device and formulation design. A review is provided of delivery mechanisms and design of the three major classes of pulmonary drug delivery devices (pressurized metered dose inhalers, nebulizers, and dry powder inhalers). For eac
34#
發(fā)表于 2025-3-27 12:17:47 | 只看該作者
35#
發(fā)表于 2025-3-27 16:48:32 | 只看該作者
AAPS Introductions in the Pharmaceutical Scienceshttp://image.papertrans.cn/e/image/315504.jpg
36#
發(fā)表于 2025-3-27 17:48:21 | 只看該作者
37#
發(fā)表于 2025-3-27 23:15:49 | 只看該作者
38#
發(fā)表于 2025-3-28 02:51:19 | 只看該作者
Capsule and Tablet Dosage Forms,egories are provided along with general functions and examples. A review of USP-recommended analytical tests is also included. Lastly, this chapter introduces techniques for formulating poorly water soluble drugs in capsule and tablet dosage forms.
39#
發(fā)表于 2025-3-28 09:46:44 | 只看該作者
Pulmonary Drug Delivery,design of the three major classes of pulmonary drug delivery devices (pressurized metered dose inhalers, nebulizers, and dry powder inhalers). For each class of device, appropriate formulation approaches are discussed.
40#
發(fā)表于 2025-3-28 13:05:30 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-20 18:36
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
南充市| 新龙县| 仪征市| 固安县| 宁城县| 邵阳县| 北海市| 北川| 安吉县| 钟祥市| 大埔县| 高雄市| 密山市| 临汾市| 抚宁县| 渑池县| 昭平县| 济阳县| 新密市| 白银市| 新野县| 泰州市| 合作市| 卫辉市| 巩义市| 天峨县| 淮南市| 石渠县| 武鸣县| 西畴县| 福清市| 昌邑市| 济宁市| 龙井市| 田阳县| 蕲春县| 潍坊市| 大洼县| 东乌| 平顶山市| 陆良县|